Since the previous update on 7 June 2023, and as of 4 July 2023, no new MERS-CoV cases and related deaths have been reported by health authorities worldwide or the World Health Organization (WHO).
Since the previous update on 3 May 2023, and as of 7 June 2023, no new MERS-CoV cases and no
related deaths have been reported by health authorities worldwide or by the World Health Organization (WHO).
Since the previous update on 3 May 2023, and as of 7 June 2023, no MERS-CoV cases have been reported by health authorities worldwide or by the World Health Organisation (WHO).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2023 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19, Mpox, Marburg virus disease and West Nile virus.
In 2019, 8 874 (7.4%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
In 2018, 9 860 (7.8%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection or urinary tract infection).
The 2016–2017 ECDC point prevalence survey was the second EU-wide point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals.